Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/NATCAPSUQ stock hub

NSE/NATCAPSUQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/NATCAPSUQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/NATCAPSUQ

In the news

Latest news · NSE/NATCAPSUQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/En/a

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC-3.9

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/NATCAPSUQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

142

Groups with data

Currency

INR

Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	619
Employees Change	19%
Employees Change Percent	3.17
Enterprise value	INR 3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE936B01015
Last refreshed	2026-05-10
Market cap	INR 1.8B
Price	INR 167
Price currency	INR
Rev Per Employee	2,806,491.11x
Sector	Healthcare
Sic	2890
Symbol	nse/NATCAPSUQ
Website	https://www.naturalcapsules.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.91%
EV Earnings	-15.71x
EV/Sales	1.73x
P/B ratio	0.72x
P/S ratio	1.01x
PE Ratio10 Y	59.94x
PE Ratio3 Y	105.65x
PE Ratio5 Y	65.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.86%
EBITDA Margin	-2.61%
Gross margin	46.27%
Gross Profit	INR 803.8M
Gross Profit Growth	2.46%
Gross Profit Growth Q	-12.85%
Gross Profit Growth3 Y	-5.18%
Gross Profit Growth5 Y	16.43%
Net Income	INR -191.7M
Net Income Growth Years	0%
Pretax Margin	-12.64%
Profit Margin	-11.03%
Profit Per Employee	INR -309,627
Profitable Years	1
Roa5y	5.06
Roe5y	10.02
ROIC	-3.88
Roic5y	7.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.41%
EPS Growth Years	0
Revenue Growth	5.63x
Revenue Growth Q	-13.88x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.49x
Revenue Growth5 Y	19.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 53.7M
Debt	INR 1.1B
Debt Equity	INR 0.46
Equity	INR 2.5B
Interest Coverage	-1.41
Net Cash	INR -1.1B
Net Cash By Market Cap	INR -60.75
Net Debt Equity	INR 0.43
Tangible Book Value	INR 2.3B
Tangible Book Value Per Share	INR 219
WACC	4.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	8.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.4%
200-day SMA	187.6
50-day SMA	154.2
50-day SMA vs 200-day SMA	50under200
All Time High	296
All Time High Change	-43.51%
All Time High Date	2025-09-26
All Time Low	136.4
All Time Low Change	22.62%
All Time Low Date	2026-03-27
ATR	8.77
Beta	-0.14
Ch YTD	0.72
High	182.8
High52	296
High52 Date	2025-09-26
High52ch	-43.51%
Low	157.1
Low52	136.4
Low52 Date	2026-03-27
Low52ch	22.62%
Ma50ch	8.45%
Price vs 200-day SMA	-10.89%
RSI	65.84
RSI Monthly	45.47
RSI Weekly	47.89
Sharpe ratio	-0.15x
Sortino ratio	-0.13
Total Return	8.07%
Tr YTD	0.72
Tr1m	9.08%
Tr1w	8.78%
Tr3m	4.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -136.5M
Operating margin	-7.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,581,602%
Shares Insiders	49.09%
Shares Qo Q	0.06%
Shares Yo Y	-8.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,781.85x
Bv Per Share	219.3
Ch1m	9.08
Ch1w	8.78
Ch1y	-16.4
Ch3m	4.42
Ch6m	-15.28
Change	3.66%
Change From Open	2.61
Close	161.3
Days Gap	1.02
Depreciation Amortization	91,125,500
Dollar Volume	1,624,515.2
Earnings Date	2026-05-26
EBIT	INR -136.5M
EBITDA	INR -45.3M
EPS	INR -20.11
F Score	0
Fiscal Year End	March
Founded	1,993
Income Tax	INR -27.9M
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Ma150	180.1
Ma150ch	-7.17%
Ma20	159.1
Ma20ch	5.1%
Next Earnings Date	2026-05-26
Open	163
Position In Range	39.3
Price Date	2026-05-08
Ptbv Ratio	0.77
Relative Volume	1.75x
Revenue	1,737,218,000x
Tax By Revenue	-1.6x
Tr6m	-15.28%
Volume	9,716

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/NATCAPSUQ pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/NATCAPSUQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/NATCAPSUQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+49.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-8.1%

Negative means the company is buying back shares.

Technical

NSE/NATCAPSUQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.8

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

-0.14

Less volatile than the market

Sharpe ratio

-0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/NATCAPSUQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NATCAPSUQ stock rating?

nse/NATCAPSUQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NATCAPSUQ analysis?

The full report lives at /stocks/nse/NATCAPSUQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NATCAPSUQ?

The latest report frames nse/NATCAPSUQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NATCAPSUQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.